ENDURING
SOLUTIONS.
enhance quality-of-life
enhance quality-of-life
Neuroview Technology is a data driven technology platform and medical device company focused on neurology outcomes. Our vision is to provide enduring solutions that enhance quality-of-life, improve clinical management and reduce cost of patient care.
REAL TIME DATA of the patient’s Neurological state with EEG.
Data is downloaded to patient’s SMART PHONE
CLOUD provides bidirectional information between the patient and care team.
DATA analytics provided for efficient clinician review
NEUROVIEW TECHNOLOGY'S breakthrough device is a small implantable subcutaneous long-term Brain monitor using EEG.
There are no long-term electroencephalography (EEG) monitor devices approved by the FDA. All EEG studies even if intensive are limited to no more than a few days providing very little information. However, all brain disorders are dynamic in nature changing over time. EEG has been in clinical use for many decades and has been utilized in vascular disease, Parkinson’s, psychiatric disorders, and mainly epilepsy.
Epilepsy affects almost 4 million adults and children in United States with up to 30% who do not effectively respond to medical therapy. To date, no reliable objective biometric measure for epilepsy and seizures exists. Physicians rely on subjective seizure reporting by patients and families which is 40-50% accurate. NEUROVIEW’S novel technology accurately identifies unrecognized seizures, prevents false characterization of events, and provides information to optimize management. Under treated or untreated seizures resulting from lack of accurate seizure recognition is associated with a poor quality of life, increases the risk of accidents and sudden death, and greatly contributes to the already high cost of epilepsy. This technology is the first long-term, minimally invasive device for EEG monitoring.
Data-driven decision-making (DDDM): data science, data analysis and intelligent programming are essential to achieve success in healthcare by democratizing and personalizing healthcare. Employing AI/ML/DDN to analyze long-term EEG data will create a comprehensive knowledge platform that is updated continuously with ongoing information and from other separate knowledge domains for personalized and group utilization by all stake holders. Improving outcomes, reducing costs, reducing time to optimum treatments, improving diagnostics, predicting outcomes, etc., is some of the anticipated personalized care that AI will bring to brain disorders.
After 30 years of treating patients with epilepsy including those undergoing epilepsy surgery, Neuroview Technology co-founders have designed this device to be easily implantable with a 15 minute minimally invasive same day surgery procedure under local anesthesia. The EEG data which it records is delivered to the cloud via smart device technology. Analytics and relevant information is available to the patient and physician 24 hours a day. This novel technology truly represents a paradigm shift in brain monitoring and the treatment of epilepsy and other neurologic disorders.
RUBEN KUZNIECKY, MD.
Learn More
Professor of Neurology and Vice-chair, academic affairs Northwell Health Hofstra University. Professor and former co-Director of NYU Epilepsy Center (2003-2017). Dr. Kuzniecky trained in Neurology and Epilepsy at the Montreal Neurological Institute. He is internationally known for his imaging work in epilepsy and for his work on malformations of cortical development and epilepsy and epilepsy genetics. Learn More
Werner Doyle, MD.
Learn More
Associate Professor in the Department of Neurosurgery at NYU and a member of the NYU Epilepsy center. He also has a degree in Mathematics. Dr. Doyle trained in Neurosurgery at NYU and Epilepsy surgery at Yale. He specializes in epilepsy surgery and collaborates with several labs in the NYU Neuroscience Institute, to study brain mechanisms, behavior and understanding the etiologic substrates of the brain that cause epilepsy.
Steven Pacia, MD
Learn More
Professor of Neurology and Vice Chair, Neurology, Nortshore University Hospital, Northwell Health. Dr. Pacia trained in Neurology and Epilepsy at the Yale School of Medicine where he studied the first intracranial EEG validated classification for temporal lobe seizures. He served as the NYU site director for the only NIH funded multicenter study of Epilepsy Surgery prior to becoming Chief of Neurology at Lenox Hill Hospital
Daniel Friedman, MD
Learn More
Assistant Professor of Neurology and a member of the Comprehensive Epilepsy Center of at NYU. He received his medical degree from Case Western Reserve University, completed neurology residency at the Hospital of University of Pennsylvania and his epilepsy and EEG fellowships at Columbia University. He also has additional training in translational research. He is the co-director of the video-EEG laboratory at NYU Langone Medical Center
JAMES KARWEL
Learn More
Jim has joined NVT this past July as CEO and a member of the board. He recently retired from Ernst & Young as a Partner in the Financial Services Organization of Ernst & Young LLP as the America’s Banking and Capital Markets (BCM) Leader. In his most recent role, he oversaw the markets strategy, clients, talent and overall business growth in this region. Jim has more than 40 years of experience building professional services businesses and advising Fortune 100 clients, government agencies, entrepreneurial startups, and JVs on successfully managing strategic global initiatives, including regulatory crisis, product development, innovation, and technology. He has spent the last 20 years serving financial services institutions, primarily in the banking and capital markets sector. He also served as the lead global client services partner for one of the firm’s largest banking and capital markets clients. Jim has worked on a global scale, including building cross functional teams to meet client and firm demands and advised boards and senior client executives on matters of strategy, risk, regulation, technology, and business transformation. Before joining EY, he worked at Robbins-Gioia, Inc., a large-scale strategic program management services firm and served the Government including U.S. Department of Defense, automotive, and telecommunications markets. He holds an MBA from the University of Dayton, and a B.S. in Mechanical Engineering from Drexel University. Jim currently serves on the board of Covenant House of New York as the vice-chairman.
Louis Rauchenberger
Board Member
Learn More
Lou Rauchenberger has served in multiple senior management positions in his 30+ year career in the financial industry. At JP Morgan, his roles included being Chief Operating Officer responsible for overseeing Technology, Operations, Quantitative Research and Customer Service. In addition, Lou has served as Controller, Chief Compliance Officer and Chief Auditor. He has extensive experience in managing large-scale technology and control agendas and has long-standing experience in working within regulatory structures and processes. He holds a Bachelor of Arts degree from Fordham University. He serves on the Board of Directors of Covenant House, New York chapter.
JAMES KARWEL
Learn More
BJim has joined NVT this past July as CEO and a member of the board. He recently retired from Ernst & Young as a Partner in the Financial Services Organization of Ernst & Young LLP as the America’s Banking and Capital Markets (BCM) Leader. In his most recent role, he oversaw the markets strategy, clients, talent and overall business growth in this region. Jim has more than 40 years of experience building professional services businesses and advising Fortune 100 clients, government agencies, entrepreneurial startups, and JVs on successfully managing strategic global initiatives, including regulatory crisis, product development, innovation, and technology. He has spent the last 20 years serving financial services institutions, primarily in the banking and capital markets sector. He also served as the lead global client services partner for one of the firm’s largest banking and capital markets clients. Jim has worked on a global scale, including building cross functional teams to meet client and firm demands and advised boards and senior client executives on matters of strategy, risk, regulation, technology, and business transformation. Before joining EY, he worked at Robbins-Gioia, Inc., a large-scale strategic program management services firm and served the Government including U.S. Department of Defense, automotive, and telecommunications markets. He holds an MBA from the University of Dayton, and a B.S. in Mechanical Engineering from Drexel University. Jim currently serves on the board of Covenant House of New York as the vice-chairman.
RUBEN KUZNIECKY, MD.
Learn More
Professor of Neurology and Vice-chair, academic affairs Northwell Health Hofstra University. Professor and former co-Director of NYU Epilepsy Center (2003-2017). Dr. Kuzniecky trained in Neurology and Epilepsy at the Montreal Neurological Institute. He is internationally known for his imaging work in epilepsy and for his work on malformations of cortical development and epilepsy and epilepsy genetics. Learn More
Werner Doyle, MD.
Learn More
Associate Professor in the Department of Neurosurgery at NYU and a member of the NYU Epilepsy center. He also has a degree in Mathematics. Dr. Doyle trained in Neurosurgery at NYU and Epilepsy surgery at Yale. He specializes in epilepsy surgery and collaborates with several labs in the NYU Neuroscience Institute, to study brain mechanisms, behavior and understanding the etiologic substrates of the brain that cause epilepsy.
Steven Pacia, MD
Learn More
Professor of Neurology and Vice Chair, Neurology, Nortshore University Hospital, Northwell Health. Dr. Pacia trained in Neurology and Epilepsy at the Yale School of Medicine where he studied the first intracranial EEG validated classification for temporal lobe seizures. He served as the NYU site director for the only NIH funded multicenter study of Epilepsy Surgery prior to becoming Chief of Neurology at Lenox Hill Hospital
Daniel Friedman, MD
Learn More
Assistant Professor of Neurology and a member of the Comprehensive Epilepsy Center of at NYU. He received his medical degree from Case Western Reserve University, completed neurology residency at the Hospital of University of Pennsylvania and his epilepsy and EEG fellowships at Columbia University. He also has additional training in translational research. He is the co-director of the video-EEG laboratory at NYU Langone Medical Center
Barbara Gibb
Learn More
Barbara has spent over 20 years building businesses and delivering sustained results in the MedTech industry. She spent the last 15 years at NeuroPace as a Director of New Product Development. Barbara is highly committed to and experienced in achieving organizational goals with a range of technical domain, R&D, quality, regulatory, IP, manufacturing and marketing experience. She is an accomplished inventor with over 30 patents. Barbara received a B.S. in Mechanical Engineering from UC Davis and M.S.E. in Biomedical Engineering from John Hopkins University.
Gil Breiman
Legal Counsel
Learn More
Gil Breiman is a Partner at the law firm of Burns & Levinson LLP. Gil is actively involved with the innovation ecosystem, representing investors, entrepreneurs and corporations launching, growing, and exiting innovative businesses in a broad spectrum of high technology and life sciences fields. Gil serves as Co-Chair of the firm’s Venture Capital & Emerging Companies Group and as Chair of the firm’s international practice. Gil has been quoted and published articles in several publications and invited to speak at venture capital and emerging company conferences and academic settings on issues pertaining to entrepreneurship, investments and international business.
Ben Pless
Consultant
Learn More
Ben Pless has over 25 years of experience developing implantable medical devices He is CEO of Pivotal Design Labs, a medical device consulting organization. Ben was President/CEO of Autonomic Technologies. Prior to that he was the COO and CTO of NeuroPace, a company that developed the first electronic implantable device for epilepsy. Before 2000, he was responsible for worldwide development for the Cardiac Rhythm Management Division of St. Jude Medical. Ben received a B.S.E.E. from MIT. He is a named inventor on over 100 patents.
John Edge
Advisor
Learn More
John Edge has spent over 20 years at the vanguard of innovation in financial markets, building, operating and advising companies that seek to disrupt the status quo. He is currently focused on the development of Web 3.0 enabled markets and the application of confidential compute in data asset finance. Previously, Mr. Edge was a FinTech entrepreneur, having co-founded Red Kite Financial Markets, a data analytics company providing regulatory compliance solutions to capital markets (sold to NICE Systems). Prior to Red Kite, he led electronic trading innovation at the capital markets groups of investment banks, including J.P. Morgan, Lehman Brothers and UBS. Mr. Edge has current academic appointments as a Connection Science Fellow at Massachusetts Institute of Technology and as a visiting Fellow at Oxford University. He is the co-founder of ID2020, a global public-private alliance championing individuals’ rights to privacy and access to decentralized technologies, and Chairman Emeritus of the Whitechapel Think Tank, a collaborative forum at the forefront of advancing global innovation in distributed ledger technologies. Mr. Edge holds a B.S. in Mechanical Engineering from the University of Leeds.
If you would like to learn more about Neuroview Technology, have a specific question, or would like to get in touch directly, please fill out the form below.